J7185 Xyntha injection
Also known as: Xyntha, Factor VIII recombinant, rFVIII
Injection of Xyntha (antihemophilic factor [recombinant]), a recombinant Factor VIII product used for hemophilia A management.
In Plain Language
hemophilia A treatment; clotting factor replacement
Clinical Context
Used for treatment and prophylaxis of bleeding in hemophilia A patients, provides recombinant Factor VIII replacement.
RVU Information
CPT J7185 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7185?
CPT J7185 (Xyntha injection) is a J Codes (Drugs) code. Injection of Xyntha (antihemophilic factor [recombinant]), a recombinant Factor VIII product used for hemophilia A management.
How is J7185 administered?
CPT J7185 is administered by a healthcare provider, typically via injection or infusion. Used for treatment and prophylaxis of bleeding in hemophilia A patients, provides recombinant Factor VIII replacement. It is used by Hematology, Hemophilia Specialty Clinic, Pediatrics.
When is CPT J7185 used?
Used for treatment and prophylaxis of bleeding in hemophilia A patients, provides recombinant Factor VIII replacement.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.